Prism for PTSD
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a software tool called Prism, designed to reduce PTSD symptoms in young people. Prism uses neurofeedback (brainwave monitoring) during training sessions to support standard PTSD treatments. The goal is to confirm Prism's safety and effectiveness for adolescents, as it has been shown for adults. Individuals who have experienced PTSD for over a year, have not completed trauma-focused therapy, and are willing to attend regular sessions might be suitable candidates. As an unphased trial, participants contribute to innovative research that may enhance PTSD treatment options for young people.
Will I have to stop taking my current medications?
The trial requires that participants do not change or start any new psychotropic medications within the 4 weeks before joining and during the study. If you are on stable medication, you can continue, but you should not plan to change it during the trial.
What prior data suggests that the Prism software device is safe for adolescents with PTSD?
Research has shown that the Prism software is safe to use. Previous studies found that using Prism for EEG neurofeedback training did not cause any serious device-related problems. In adults with PTSD (post-traumatic stress disorder), participants completed 15 training sessions without major safety issues.
The FDA has already approved the Prism software for use in adults, indicating it meets strict safety standards. This trial aims to confirm its safety for teens with PTSD. So far, evidence suggests that Prism is well-tolerated, with no serious device-related problems reported.12345Why are researchers excited about this trial?
Prism is unique because it uses neurofeedback training to help people with PTSD. Unlike traditional treatments like medication and talk therapy, which focus on managing symptoms, Prism aims to retrain the brain's activity patterns. Researchers are excited about this approach because it offers a non-invasive way to address PTSD by potentially altering the brain's response to stress, providing a new avenue for treatment that could complement existing therapies.
What evidence suggests that the Prism software device is effective for treating PTSD in adolescents?
Research has shown that Prism neurofeedback training can help reduce PTSD symptoms. In one study, participants experienced a symptom reduction ranging from 7% to 72%, with an average decrease of 42.5%. This indicates that the Prism system can significantly aid many individuals with PTSD. Previous studies have also found Prism to be safe and effective for adults. In this trial, all participants will undergo Prism neurofeedback training to test these results in teenagers, focusing on safety and symptom reduction.12456
Who Is on the Research Team?
ADAR SHANI
Principal Investigator
GrayMatters Health
Are You a Good Fit for This Trial?
This trial is for adolescents with PTSD. Participants will use a software called Prism, which requires them to have EEG-NF training sessions. The goal is to see if it's safe and helps reduce PTSD symptoms in young people.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Prism neurofeedback training sessions delivered twice per week over 8 consecutive weeks
Mid-training Assessment
Assessment after 7 neurofeedback training sessions to evaluate progress
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Prism
Find a Clinic Near You
Who Is Running the Clinical Trial?
GrayMatters Health Ltd.
Lead Sponsor